REGENOCELL THERAPEUTICS, INC. Operating Income
REGENOCELL THERAPEUTICS, INC. reported Operating Income of -$862.87 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-05-25.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-05-25
- REGENOCELL THERAPEUTICS, INC. operating income (loss) for the quarter ending 2011-12-31 was -$222.10K.
- REGENOCELL THERAPEUTICS, INC. operating income (loss) for the quarter ending 2011-09-30 was -$315.64K.
- REGENOCELL THERAPEUTICS, INC. operating income (loss) for the quarter ending 2011-06-30 was -$276.25K, a 501.81% decline year-over-year.
- REGENOCELL THERAPEUTICS, INC. operating income (loss) for the quarter ending 2010-12-31 was -$2.90M.
- REGENOCELL THERAPEUTICS, INC. operating income (loss) for fiscal 2011 was -$862.87K.
- REGENOCELL THERAPEUTICS, INC. operating income (loss) for fiscal 2010 was -$3.56M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$222.10K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | -$537.74K derived: sum of 2 quarters · filed 2012-05-25 | -$813.99K derived: sum of 3 quarters · filed 2012-05-25 | -$862.87K 10-K · filed 2012-05-25 |
| 2011-09-30 | -$315.64K 10-Q · filed 2011-11-21 | -$591.89K derived: sum of 2 quarters · filed 2011-11-21 | -$640.77K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | -$276.25K 10-Q/A · filed 2011-09-01 | -$325.14K 10-Q/A · filed 2011-09-01 | ||
| 2010-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | -$3.31M derived: sum of 2 quarters · filed 2012-05-25 | -$3.24M derived: sum of 3 quarters · filed 2012-05-25 | -$3.56M 10-K · filed 2012-05-25 |
| 2010-09-30 | -$410.34K 10-Q · filed 2011-11-21 | -$341.59K derived: sum of 2 quarters · filed 2011-11-21 | -$658.07K 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $68.75K 10-Q/A · filed 2011-09-01 | -$232.68K 10-Q/A · filed 2011-09-01 |